The Aurum Institute is pleased to announce the enrolment of the first participant in its clinical trial testing two host-directed therapies (HDTs) in patients with drug-resistant tuberculosis (DRTB-HDT). The milestone was reached by the study team at the Isango Lethemba TB Research Unit in Port Elizabeth, South Africa, under the direction of Dr Francesca Conradie....